Skip to content
StockMarketAgent
Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300199 stock hub

SHE/300199 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

SHE/300199is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
18.1B
Shenzhen Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
SHE/300199
In the news

Latest news · SHE/300199

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 17.1P50 24.2P75 37.8
Trailing P/E199.9
P25 23.5P50 41.3P75 83.2
ROE12.9
P25 -0.9P50 4.1P75 8.8
ROIC6.7
P25 -0.5P50 5P75 11.4
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All SHE/300199 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
209
Groups with data
11
Currency
CNY
Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
China
Country code
CN
Employees
1,035
Employees Change
140%
Employees Change Percent
15.64
Enterprise value
CNY 19.9B
Exchange
Shenzhen Stock Exchange
Financial currency
CNY
First seen
2026-05-10
Industry
Drug Manufacturers - Specialty & Generic
Isin
CNE1000011T7
Last refreshed
2026-05-10
Market cap
CNY 18.1B
Price
CNY 20.44
Price currency
CNY
Rev Per Employee
923,215.5x
Sector
Healthcare
Sic
2834
Symbol
she/300199
Website
https://www.hybio.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
0.52%
EV Earnings
210.72x
EV/EBIT
71.79x
EV/EBITDA
48.98x
EV/FCF
-1,429.49x
EV/Sales
20.84x
FCF yield
-0.08%
P/B ratio
23.85x
P/E ratio
199.86x
P/S ratio
18.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

23
MetricValue
EBIT Margin
24.07%
EBITDA Margin
37.51%
Gross margin
60.31%
Gross Profit
CNY 576.2M
Gross Profit Growth
34.64%
Gross Profit Growth Q
6.74%
Gross Profit Growth3 Y
4.38%
Gross Profit Growth5 Y
1.1%
Net Income
CNY 94.5M
Net Income Growth Q
82.94%
Net Income Growth Quarters
2%
Net Income Growth Years
2%
Pretax Margin
13.06%
Profit Margin
9.89%
Profit Per Employee
CNY 91,319
Profitable Years
1
ROA
4.49
Roa5y
-2.05
ROCE
12.57
ROE
12.92
Roe5y
-18.74
ROIC
6.73
Roic5y
-4.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

18
MetricValue
Cagr10y
0.93%
Cagr15y
11.73%
Cagr1y
38.14%
Cagr3y
23.61%
Cagr5y
29.65%
Div CAGR10
28.21%
EPS Growth Q
75
EPS Growth Quarters
2
EPS Growth Years
2
OCF Growth
38.92%
OCF Growth Q
74.23%
OCF Growth10 Y
13.98%
OCF Growth5 Y
10.89%
Revenue Growth
27.42x
Revenue Growth Q
-3.49x
Revenue Growth Years
2x
Revenue Growth3 Y
10.23x
Revenue Growth5 Y
6.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

20
MetricValue
Asset Turnover
CNY 0.3
Assets
CNY 3.4B
Cash
CNY 108.7M
Current Assets
CNY 659.3M
Current Liabilities
CNY 1.5B
Debt
CNY 2B
Debt EBITDA
CNY 5.44
Debt Equity
CNY 2.58
Debt FCF
CNY -140
Equity
CNY 757.1M
Liabilities
CNY 2.6B
Long Term Assets
CNY 2.7B
Long Term Liabilities
CNY 1.1B
Net Cash
CNY -1.8B
Net Cash By Market Cap
CNY -10.23
Net Debt EBITDA
CNY 5.15
Net Debt Equity
CNY 2.44
Tangible Book Value
CNY 404.7M
Tangible Book Value Per Share
CNY 0.44
WACC
7.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.43
Inventory Turnover
1.35
Net Working Capital
CNY 12.6M
Quick ratio
0.19
Working Capital
CNY -878.6M
Working Capital Turnover
CNY -0.97

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

4
MetricValue
Buyback Yield
-1.52%
Dividend per share
CNY 0
Last Dividend
CNY 0.2
Payout Ratio
102.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
9.68%
1Y total return
38.11%
200-day SMA
20.68
3Y total return
88.91%
50-day SMA
19.45
50-day SMA vs 200-day SMA
50under200
5Y total return
266.31%
All Time High
52.76
All Time High Change
-61.26%
All Time High Date
2015-06-10
All Time Low
2.79
All Time Low Change
632.62%
All Time Low Date
2012-12-04
ATR
0.87
Beta
0.72
Beta1y
0.85
Beta2y
0.71
Ch YTD
14.19
High
20.92
High52
31.19
High52 Date
2025-08-20
High52ch
-34.47%
Low
20.4
Low52
13.46
Low52 Date
2025-05-26
Low52ch
51.86%
Ma50ch
5.11%
Price vs 200-day SMA
-1.15%
RSI
47.51
RSI Monthly
58.31
RSI Weekly
53.94
Sharpe ratio
0.93x
Sortino ratio
1.62
Total Return
-1.52%
Tr YTD
14.19
Tr15y
427.91%
Tr1m
4.82%
Tr1w
-2.25%
Tr3m
9.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
CNY 230M
Operating Income Growth
120.2
Operating Income Growth Q
19.49
Operating margin
24.07

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
647,392,829%
Net Borrowing
-62,496,994
Shares Insiders
24.44%
Shares Institutions
3.81%
Shares Out
883,241,336
Shares Qo Q
-6.97%
Shares Yo Y
1.52%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

58
MetricValue
Adjusted FCF
CNY -13.9M
Average Volume
52,596,340x
Bv Per Share
0.81
CAPEX
CNY -277.8M
Ch10y
7.41
Ch15y
406.4
Ch1m
4.82
Ch1w
-2.25
Ch1y
38.11
Ch3m
9.6
Ch3y
88.91
Ch5y
266.3
Ch6m
-0.15
Change
-2.57%
Change From Open
-1.64
Close
20.98
Days Gap
-0.95
Depreciation Amortization
128,422,030
Dollar Volume
760,386,763.9
Earnings Date
2026-04-29
EBIT
CNY 230M
EBITDA
CNY 358.4M
EPS
CNY 0.1
F Score
7
FCF
CNY -13.9M
FCF EV Yield
-0.07x
FCF Per Share
CNY -0.02
Financing CF
50,827,547
Fiscal Year End
December
Founded
1,998
Graham Number
1.36716
Graham Upside
-93.31
Income Tax
CNY 32.8M
Investing CF
-278,654,434
Is Primary Listing
1
Last Earnings Date
2026-04-29
Last Report Date
2026-03-31
Last Split Date
2015-04-14
Last Split Type
Forward
Ma150
19.76
Ma150ch
3.43%
Ma20
21.34
Ma20ch
-4.22%
Net CF
34,480,802
Next Earnings Date
2026-08-21
Open
20.78
P OCF Ratio
68.41
Position In Range
7.69
Ppne
1,766,814,141
Price Date
2026-05-08
Price EBITDA
CNY 50.37
Ptbv Ratio
44.61
Relative Volume
0.72x
Revenue
955,528,038x
Tax By Revenue
3.43x
Tax Rate
26.28%
Tr6m
-0.15%
Volume
37,200,918
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does SHE/300199 pay a dividend?

Capital-return profile for this ticker.

Performance

SHE/300199 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+38.1%
S&P 500 1Y: n/a
3Y total return
+88.9%
S&P 500 3Y: n/a
5Y total return
+266.3%
S&P 500 5Y: n/a
10Y total return
+9.7%
S&P 500 10Y: n/a
Ownership

Who owns SHE/300199?

Insider, institutional, and short-interest positioning.

Institutional ownership
+3.8%
Share of float held by funds and institutions
Insider ownership
+24.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+1.5%
Negative means the company is buying back shares.
Technical

SHE/300199 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
47.5
Neutral momentum band
Price vs 200-day MA
-1.1%
50/200-day relationship not available
Beta (5Y)
0.72
Less volatile than the market
Sharpe ratio
0.93
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About SHE/300199

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300199 stock rating?

she/300199 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300199 analysis?

The full report lives at /stocks/she/300199/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300199?

The latest report frames she/300199 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300199 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.